Petros Pharmaceuticals Inc. (PTPI)
$0.00
$-0.04
(-91.56%)
As on 01-Sep-2026 15:46EDT
Market cap
$0 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
0
P/B Ratio
0.3
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-1.2 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-0.1
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-0.1
-
Face value
--
-
Shares outstanding
42,372,260
6 Years Aggregate
CFO
$-37.04 Mln
EBITDA
$-47.56 Mln
Net Profit
$-97.65 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Petros Pharmaceuticals (PTPI)
| -- | -- | -- | -- | -96.0 | -90.7 | -- |
|
BSE Sensex*
| -9.8 | -2.2 | 2.9 | -4.9 | 5.3 | 5.9 | 10.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|
|
Petros Pharmaceuticals (PTPI)
| -71.8 | -39.5 | -93.0 | -24.3 |
|
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 | 25.3 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Petros Pharmaceuticals (PTPI)
|
0.0 | 0.2 | 0.0 | -3.2 | -- | -179.3 | 0 | 0.3 |
| 82.7 | 11,993.9 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.9 | |
| 260.3 | 16,261.1 | 1,054.4 | 755.9 | 5.7 | -- | 19 | 9.8 | |
| 71.4 | 10,022.2 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.3 | |
| 56.9 | 13,491.7 | 2,435.9 | 860.6 | 31.0 | 43 | 17.4 | 7.4 | |
| 107.7 | 11,957.0 | 1,663.7 | 413.6 | 36.3 | 430 | 30.9 | 84.5 | |
| 363.8 | 10,402.8 | 440.5 | 241.5 | 33.4 | 18.7 | 44.1 | 7.8 | |
| 538.7 | 12,332.1 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 24.0 | |
| 583.2 | 16,765.1 | 2,782.3 | 491.5 | 21.1 | 110.1 | 35.2 | 39.3 | |
| 353.4 | 9,625.4 | 0.0 | -339.1 | -- | -30.6 | -- | 7.6 |
Shareholding Pattern
View DetailsAbout Petros Pharmaceuticals (PTPI)
Petros Pharmaceuticals, Inc., a healthcare technology company, focuses on developing and licensing proprietary software as a service (SaaS) platform and Software as a medical device web application designed to assist pharmaceutical companies. The... company is based in New York, New York. Read more
-
Executive Chairman of the Board
Mr. John David Shulman
-
Executive Chairman of the Board
Mr. John David Shulman
-
Headquarters
New York, NY
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Petros Pharmaceuticals (PTPI)
What is the current share price of Petros Pharmaceuticals Inc (PTPI) Today?
The share price of Petros Pharmaceuticals Inc (PTPI) is $0.00 (NASDAQ) as of 01-Sep-2026 15:46 EDT. Petros Pharmaceuticals Inc (PTPI) has given a return of -96.03% in the last 3 years.
What is the current PB & PE ratio of Petros Pharmaceuticals Inc (PTPI)?
Since, TTM earnings of Petros Pharmaceuticals Inc (PTPI) is negative, P/E ratio is not available.
The P/B ratio of Petros Pharmaceuticals Inc (PTPI) is 0.27 times as on 28-Aug-2026, a 95 discount to its peers’ median range of 5.18 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-- |
-- |
2024 |
-0.22 |
-0.42 |
2023 |
-0.52 |
0.34 |
2022 |
-0.24 |
0.29 |
2021 |
-0.53 |
0.13 |
What is the 52 Week High and Low of Petros Pharmaceuticals Inc (PTPI)?
The 52-week high and low of Petros Pharmaceuticals Inc (PTPI) are Rs 0.01 and Rs 0.00 as of 02-Sep-2026.
What is the market cap of Petros Pharmaceuticals Inc (PTPI)?
Petros Pharmaceuticals Inc (PTPI) has a market capitalisation of $ 0 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Petros Pharmaceuticals Inc (PTPI)?
Before investing in Petros Pharmaceuticals Inc (PTPI), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.